ITK

IL2 inducible T cell kinase, the group of Tec family tyrosine kinases|SH2 domain containing|Pleckstrin homology domain containing

Basic information

Region (hg38): 5:157142933-157255185

Links

ENSG00000113263NCBI:3702OMIM:186973HGNC:6171Uniprot:Q08881AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • lymphoproliferative syndrome 1 (Strong), mode of inheritance: AR
  • lymphoproliferative syndrome 1 (Moderate), mode of inheritance: AR
  • lymphoproliferative syndrome 1 (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Lymphoproliferative syndrome 1ARAllergy/Immunology/Infectious; OncologicDue to the risk of malignancy, surveillance may allow prompt treatment; Medical treatment (eg, chemotherapy, virostatic agents, corticosteroids, rituximab) may induce remission, but treatment with HSCT may be required; Antiinfectious prophylaxis and early and aggressive treatment of infections may be beneficialAllergy/Immunology/Infectious; Oncologic19425169; 21109689; 22289921; 22487848
Individuals may also have related predisposition to infectious complications

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ITK gene.

  • Lymphoproliferative syndrome 1 (7 variants)
  • not provided (1 variants)
  • Inborn genetic diseases (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ITK gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
3
clinvar
106
clinvar
2
clinvar
111
missense
167
clinvar
6
clinvar
173
nonsense
6
clinvar
6
start loss
0
frameshift
3
clinvar
1
clinvar
4
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
1
clinvar
2
clinvar
3
splice region
9
17
1
27
non coding
37
clinvar
59
clinvar
39
clinvar
135
Total 9 2 210 171 41

Highest pathogenic variant AF is 0.00000657

Variants in ITK

This is a list of pathogenic ClinVar variants found in the ITK region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
5-157162458-T-C not specified Uncertain significance (Aug 08, 2023)2616995
5-157162481-G-A not specified Likely benign (Jan 03, 2024)3098395
5-157162508-A-G not specified Uncertain significance (Dec 15, 2022)3098394
5-157162559-T-G not specified Uncertain significance (Apr 13, 2023)2536952
5-157162597-T-G not specified Uncertain significance (Feb 06, 2024)3098392
5-157162626-A-G not specified Uncertain significance (Feb 21, 2024)3098391
5-157162649-C-T Likely benign (Apr 01, 2024)2655990
5-157162671-T-A not specified Uncertain significance (Dec 12, 2023)3098390
5-157162704-C-G not specified Uncertain significance (Aug 01, 2022)3098389
5-157162769-C-A not specified Uncertain significance (Jan 23, 2024)3098388
5-157162804-G-T not specified Uncertain significance (Oct 19, 2021)3098387
5-157162887-T-C not specified Uncertain significance (May 08, 2024)3280721
5-157162899-T-C not specified Uncertain significance (Aug 01, 2022)3098386
5-157162900-C-G not specified Uncertain significance (Oct 04, 2022)3098385
5-157162925-C-A not specified Uncertain significance (Jul 19, 2022)3098384
5-157163061-A-C not specified Uncertain significance (Dec 08, 2023)3098383
5-157163064-T-C not specified Uncertain significance (Feb 26, 2024)3098382
5-157163087-G-T not specified Uncertain significance (Oct 02, 2023)3098381
5-157163226-C-T not specified Uncertain significance (Dec 18, 2023)3098380
5-157163239-G-T not specified Uncertain significance (Apr 25, 2023)2540561
5-157163246-C-A not specified Uncertain significance (Nov 09, 2023)3098379
5-157163252-G-A not specified Uncertain significance (Apr 09, 2024)3280720
5-157163256-A-T not specified Uncertain significance (Oct 06, 2022)3098378
5-157163261-T-C not specified Likely benign (Sep 21, 2023)3098377
5-157163273-G-A not specified Uncertain significance (Aug 13, 2021)3098414

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ITKprotein_codingprotein_codingENST00000422843 17112258
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
3.14e-80.9991257220261257480.000103
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.532533310.7640.00001974072
Missense in Polyphen76138.650.548131682
Synonymous-2.041511221.240.000006971153
Loss of Function2.981939.10.4850.00000223450

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001480.000148
Ashkenazi Jewish0.000.00
East Asian0.00005440.0000544
Finnish0.00004620.0000462
European (Non-Finnish)0.0001320.000132
Middle Eastern0.00005440.0000544
South Asian0.0001630.000163
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Tyrosine kinase that plays an essential role in regulation of the adaptive immune response. Regulates the development, function and differentiation of conventional T-cells and nonconventional NKT-cells. When antigen presenting cells (APC) activate T-cell receptor (TCR), a series of phosphorylation lead to the recruitment of ITK to the cell membrane, in the vicinity of the stimulated TCR receptor, where it is phosphorylated by LCK. Phosphorylation leads to ITK autophosphorylation and full activation. Once activated, phosphorylates PLCG1, leading to the activation of this lipase and subsequent cleavage of its substrates. In turn, the endoplasmic reticulum releases calcium in the cytoplasm and the nuclear activator of activated T-cells (NFAT) translocates into the nucleus to perform its transcriptional duty. Phosphorylates 2 essential adapter proteins: the linker for activation of T-cells/LAT protein and LCP2. Then, a large number of signaling molecules such as VAV1 are recruited and ultimately lead to lymphokine production, T-cell proliferation and differentiation (PubMed:12186560, PubMed:12682224, PubMed:21725281). Phosphorylates TBX21 at 'Tyr-530' and mediates its interaction with GATA3 (By similarity). {ECO:0000250|UniProtKB:Q03526, ECO:0000269|PubMed:12186560, ECO:0000269|PubMed:12682224, ECO:0000269|PubMed:21725281}.;
Disease
DISEASE: Lymphoproliferative syndrome 1 (LPFS1) [MIM:613011]: A rare immunodeficiency characterized by extreme susceptibility to infection with Epstein-Barr virus (EBV). Inadequate immune response to EBV can have a fatal outcome. Clinical features include splenomegaly, lymphadenopathy, anemia, thrombocytopenia, pancytopenia, recurrent infections. There is an increased risk for lymphoma. {ECO:0000269|PubMed:19425169}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
T cell receptor signaling pathway - Homo sapiens (human);Chemokine signaling pathway - Homo sapiens (human);Leukocyte transendothelial migration - Homo sapiens (human);T-Cell Receptor and Co-stimulatory Signaling;T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection;Chemokine signaling pathway;T-Cell antigen Receptor (TCR) Signaling Pathway;the co-stimulatory signal during t-cell activation;Generation of second messenger molecules;TCR signaling;CD4 T cell receptor signaling-ERK cascade;FCERI mediated Ca+2 mobilization;Fc epsilon receptor (FCERI) signaling;TCR;Innate Immune System;Immune System;Adaptive Immune System;BCR;IL-7 signaling;JAK STAT pathway and regulation;EPO signaling;Class I PI3K signaling events;VEGF;Fc-epsilon receptor I signaling in mast cells;TCR signaling in naïve CD4+ T cells;CD4 T cell receptor signaling-JNK cascade;CD4 T cell receptor signaling-NFkB cascade;CD4 T cell receptor signaling (Consensus)

Recessive Scores

pRec
0.367

Intolerance Scores

loftool
0.261
rvis_EVS
-0.22
rvis_percentile_EVS
37.43

Haploinsufficiency Scores

pHI
0.568
hipred
Y
hipred_score
0.624
ghis
0.511

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.767

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Itk
Phenotype
immune system phenotype; hematopoietic system phenotype; cellular phenotype; endocrine/exocrine gland phenotype;

Gene ontology

Biological process
cytokine production;NK T cell differentiation;adaptive immune response;cellular defense response;signal transduction;activation of phospholipase C activity;interferon-gamma production;interleukin-4 production;intracellular signal transduction;peptidyl-tyrosine autophosphorylation;Fc-epsilon receptor signaling pathway;T cell activation;T cell receptor signaling pathway;B cell receptor signaling pathway
Cellular component
nucleus;cytosol;cell-cell junction
Molecular function
non-membrane spanning protein tyrosine kinase activity;protein binding;ATP binding;metal ion binding